Kai Kupferschmidt: Latest News

All news where Kai Kupferschmidt is mentioned

23.06.2021 / 22:23

Delta variant triggers dangerous new phase in the pandemic

Kai Kupferschmidt, Meredith WadmanScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.When the coronavirus variant now called Delta first appeared in December 2020, in the Indian state of Maharashtra, it did not seem all that remarkable. But when it descended on New Delhi a few months later, its impact was devastating, with almost 30,000 cases reported daily in late April.

Kai Kupferschmidt city New Delhi India hospital virus vaccine

A rare clotting disorder may cloud the world's hopes for AstraZeneca's COVID-19 vaccine

Kai Kupferschmidt, Gretchen VogelScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.In the tumultuous rollout of AstraZeneca's COVID-19 vaccine, all eyes were on the United States this week, where the company had a highly public communication breakdown over the vaccine's efficacy with an expert panel overseeing a large study in the Americas.

Kai Kupferschmidt Usa Germany covid-19 vaccine patient

Could a rare clotting disorder dash the world's hopes for AstraZeneca's COVID-19 vaccine?

Kai Kupferschmidt Usa Germany covid-19 vaccine patient

AstraZeneca reports powerful COVID-19 protection in new vaccine trial

Kai Kupferschmidt, Gretchen VogelScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.The long-awaited results from a new trial of AstraZeneca’s COVID-19 vaccine hold some good news for the company, which in recent weeks has had to address eroding confidence in its shots amid news of possible rare, serious side effects. In a press release published on Monday morning, the company announced that the trial, which included more than 32,000 participants in Chile, Peru, and the United States, had shown the vaccine to have 79% efficacy at preventing symptomatic COVID-19.“I’m thrilled,” says Ashish Jha, dean of Brown University’s School of Public Health.

Kai Kupferschmidt Ashish Jha Usa Chile Peru covid-19 vaccine

European countries resume use of AstraZeneca's COVID-19 vaccine, hoping pause has not dented confidence

Kai Kupferschmidt, Gretchen VogelScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.A dozen European countries today said they will resume vaccinations with the AstraZeneca vaccine against COVID-19 after the European Medicines Agency (EMA) said its initial investigation of possible side effects has concluded the vaccine is “safe and effective.” Their decisions came as a relief to many public health experts, who worried about long delays in the COVID-19 vaccination programs at a time when cases are increasing in much of Europe.At a press conference this afternoon, EMA officials said their inquiry could not rule out a connection between the vaccine and certain unusual clotting and bleeding disorders, but they concluded

Kai Kupferschmidt covid-19 vaccine

In FDA’s green light for treating COVID-19 with plasma, critics see thin evidence—and politics

Kai Kupferschmidt, Jon CohenScience’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.At a highly unusual Sunday night press conference, U.S. President Donald Trump revealed what he described as “a very historic breakthrough” in the fight against COVID-19 that “would save countless lives”: The U.S.

Donald Trump Kai Kupferschmidt covid-19 president patient

How countries could recover from coronavirus, and lessons from an ancient drought

Contributing Correspondent Kai Kupferschmidt talks with host Sarah Crespi about countries planning a comeback from a coronavirus crisis. What can they do once cases have slowed down to go back to some sort of normal without a second wave of infection? See all of our News coverage of the pandemic here. See all of our Research and Editorials here.

Kai Kupferschmidt Sarah Crespi Usa state California Peru county Santa Barbara pandemic crisis infection Coronavirus

How COVID-19 disease models shape shutdowns, and detecting emotions in mice

On this week’s show, Contributing Correspondent Kai Kupferschmidt talks with host Sarah Crespi about modeling coronavirus spread and the role of forecasts in national lockdowns and other pandemic policies. They also talk about the launch of a global trial of promising treatments. See all of our News coverage of the pandemic here. See all of our Research and Editorials here.

Kai Kupferschmidt covid-19 pandemic Coronavirus

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0